Eisai

are valuable in the healthcare industry as they are dedicated to improving human health and wellbeing. Eisai specializes in pharmaceuticals and consumer health products, with a focus on neurology, oncology, and critical care.
Some of their popular products and services include:
1. Lenvima: A medication for the treatment of certain types of cancer, including thyroid, liver, and endometrial cancer.
2. Halaven: A chemotherapy medication for the treatment of metastatic breast cancer.
3. Fycompa: An anti-epileptic medication used to treat seizures associated with epilepsy.
4. Belviq: A weight loss medication used to help adults who are obese or overweight with weight-related medical problems lose weight.
5. Perjeta: A medication used in combination with other drugs to treat HER2-positive breast cancer.
6. Zonegran: An anti-epileptic medication used as an adjunctive therapy in the treatment of partial seizures.
7. Akynzeo: A medication used for the prevention of nausea and vomiting in chemotherapy patients.
8. Dayvigo: A medication used for the treatment of insomnia in adults.
In addition to these products, Eisai also offers support programs for patients and healthcare professionals, as well as research and development initiatives to advance treatments for various diseases and conditions. They also have a strong commitment to social responsibility and sustainability, working towards making a positive impact on society and the environment.